Johnson & Johnson
F:JNJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Johnson & Johnson
F:JNJ
|
US |
|
B
|
Beiersdorf AG
F:BEI
|
DE |
|
Vimian Group AB
OTC:VIMGF
|
SE |
|
International Paper Co
LSE:IPC
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
N
|
Nestle SA
BMV:NESNN
|
CH |
|
Kimberly-Clark Corp
NASDAQ:KMB
|
US |
|
Prosus NV
XETRA:1TY
|
NL |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
P
|
Packaging Corp of America
LSE:0KEZ
|
US |
|
Walmart Inc
MIL:1WMT
|
US |
|
R
|
RPM International Inc
F:RP8
|
US |
|
B
|
Brown & Brown Inc
F:BTW
|
US |
|
S
|
Sanofi SA
XHAN:SNW
|
FR |
|
Formula One Group
NASDAQ:LLYVA
|
US |
|
Eicher Motors Ltd
BSE:505200
|
IN |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
K
|
Kimberly-Clark Corp
XMUN:KMY
|
US |
|
M
|
Masco Corp
SWB:MSQ
|
US |
|
WEX Inc
NYSE:WEX
|
US |
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
Bankruptcy Probability
Johnson & Johnson's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Johnson & Johnson Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
174.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
87.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
75.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Johnson & Johnson's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Johnson & Johnson has total debt of 47.2B USD. This includes both short-term (9.9B USD) and long-term (37.3B USD) debt.
You can find a full breakdown on its Balance Sheet.